ChemPartner Opens Boston Center of Excellence to Expand U.S. CDMO and CRO Services

  • ChemPartner will open its Boston Center of Excellence on 10 September 2025, providing discovery and preclinical services to biopharma clients in North America.
  • The 12,000-square-foot facility will offer biologics discovery, pharmacology, and DMPK services, supporting both in vitro and in vivo studies from early discovery through IND-enabling stages.

ChemPartner, a global CRO and CDMO, has announced its strategic expansion in the U.S. with the opening of the Boston Center of Excellence. The 12,000-square-foot R&D site, located at 480 Arsenal Way in Watertown, Massachusetts, will commence operations on 10 September 2025, providing discovery and preclinical services to North American biopharma clients.

The new Boston facility is designed to strengthen collaboration with local biotech and pharmaceutical companies. It will offer biologics discovery, pharmacology, and DMPK services, supporting both in vitro and in vivo studies from early discovery through IND-enabling stages. As part of ChemPartner’s global network, the site aims to improve logistics, enable faster coordination across regions, and provide onshore capabilities for clients requiring U.S.-based support.

William Woo, Chairman and CEO of ChemPartner, said: “As demand grows for more localized, agile, and collaborative research partnerships, this expansion reflects our commitment to meeting clients where they are – both scientifically and geographically. We’re excited to embed ourselves in the Boston life sciences hub, strengthen client partnerships, and deliver more personalized, streamlined support across the drug discovery and development pipeline.”

Yinfei Yin, Managing Director at ChemPartner, added that the Boston Center of Excellence will help clients navigate increasing complexity in service needs, regulatory requirements, and shipping restrictions, while maintaining the company’s scientific expertise.

Equipment installation at the new site is already underway, with an experienced scientific team in place to support initial projects scheduled to launch in the fall.

CDMO News Analysed

The latest CDMO investments, partnerships, and market intelligence.

Real-time news analysis

  • Full tracker of partnerships and strategic announcements.
  • Deal value of disclosed investment
  • Regional and modality trends

Fill out the form below for immediate access:

Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.